Cargando…

Immunoscore(®) as a predictor of response to chemotherapy in stage II and stage III colon cancer

Detalles Bibliográficos
Autores principales:	Mlecnik, Bernhard, Berger, Anne, Pages, Franck, Galon, Jerome
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645445/ http://dx.doi.org/10.1186/2051-1426-3-S2-P89

Ejemplares similares

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer
por: Sinicrope, Frank A, et al.
Publicado: (2020)

Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients
por: Baldin, Pamela, et al.
Publicado: (2020)

Usefulness and robustness of Immunoscore for personalized management of cancer patients
por: Marliot, Florence, et al.
Publicado: (2020)

The consensus immunoscore: toward a new classification of colorectal cancer
por: Lanzi, Anastasia, et al.
Publicado: (2020)

Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer
por: El Sissy, Carine, et al.
Publicado: (2021)

The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions
por: Pagès, Franck, et al.
Publicado: (2020)

The impact of cellular senescence and DNA damage on colorectal tumour progression
por: Angell, Helen K, et al.
Publicado: (2013)

Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response
por: Hijazi, Assia, et al.
Publicado: (2023)

Immunoregulation and genotype in colorectal cancer
por: Church, Sarah E, et al.
Publicado: (2015)

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer
por: Mlecnik, Bernhard, et al.
Publicado: (2023)

Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore
por: Baldin, Pamela, et al.
Publicado: (2020)

Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer
por: Marliot, Florence, et al.
Publicado: (2020)

Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer
por: Wang, Fulong, et al.
Publicado: (2023)

Prognostic value of a modified Immunoscore in patients with stage I−III resectable colon cancer
por: Zhao, Ke, et al.
Publicado: (2021)

Impact of Immunoscore on the Management of Stage II Colon Cancer Patients: A Physician Survey
por: Kasi, Anup, et al.
Publicado: (2021)

Multi-Institutional Evaluation of Pathologists’ Assessment Compared to Immunoscore
por: Willis, Joseph, et al.
Publicado: (2023)

Tumor immunosurveillance in human cancers
por: Mlecnik, Bernhard, et al.
Publicado: (2011)

No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study
por: Ascierto, Paolo A., et al.
Publicado: (2020)

Immunoscore: a new possible approach for melanoma classification
por: Capone, Mariaelena, et al.
Publicado: (2014)

The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall Survival
por: Nassif, Elise F., et al.
Publicado: (2021)

Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3(+), CD8(+), and Immunoscore Are Associated with a Pathological Complete Response
por: Rapoport, Bernardo Leon, et al.
Publicado: (2022)

MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab
por: Bifulco, Carlo, et al.
Publicado: (2014)

Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
por: Galon, Jérôme, et al.
Publicado: (2014)

Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer
por: Nassif, Elise F., et al.
Publicado: (2021)

Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction
por: Mlecnik, Bernhard, et al.
Publicado: (2010)

Programmed cell death-ligand 1 expression and immunoscore in stage II and III non-small cell lung cancer patients receiving adjuvant chemotherapy
por: Ishii, Hidenobu, et al.
Publicado: (2017)

Comparison of Immune Response Assessment in Colon Cancer by Immunoscore (Automated Digital Pathology) and Pathologist Visual Scoring
por: Boquet, Isabelle, et al.
Publicado: (2022)

World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016
por: Galon, Jerome, et al.
Publicado: (2017)

Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients
por: Zhao, Zihuan, et al.
Publicado: (2020)

The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life?
por: Kirilovsky, Amos, et al.
Publicado: (2022)

Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

Predictors of recurrence free survival for patients with stage II and III colon cancer
por: Tsikitis, Vassiliki L, et al.
Publicado: (2014)

Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy
por: Stoll, Gautier, et al.
Publicado: (2014)

Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients
por: Morse, Michael A, et al.
Publicado: (2015)

Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa
por: Tan, Sarah Xinhui, et al.
Publicado: (2023)

Correcting for selection bias in two-stage trials with multiple correlated outcomes: application to seamless phase ii/iii clinical trials
por: Robertson, David, et al.
Publicado: (2015)

The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions
por: Lanzi, Anastasia, et al.
Publicado: (2020)

Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015
por: Galon, J., et al.
Publicado: (2016)

A Phase I study of AD5-GUCY2C-PADRE in stage I and II colon cancer patients
por: Snook, Adam, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9lrlu53fa5subf7rqsrb5nm4vo